EMA Turns Down Minoryx’s Orphan Drug Nezglyal & Apellis’ Syfovre, OKs Three Others

 
• By Eliza Slawther

The European Medicines Agency has recommended against the pan-EU marketing approval of two new medicines, while three others received positive opinions on marketing authorization.

Thumb up and thumb down
• Source: Shutterstock

More from Approvals

More from Product Reviews